For the quarter ending 2025-09-30, ATHA has $30,033K in assets. $3,247K in debts. $20,874K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 20,874 | 19,888 | ||
| Short-term investments | 4,352 | 9,935 | ||
| Prepaid expenses and other current assets | 1,799 | 2,395 | ||
| Total current assets | 27,025 | 32,218 | ||
| Restricted cash | 631 | 631 | ||
| Property and equipment, at cost | 5,739 | - | ||
| Less accumulated depreciation | 4,024 | - | ||
| Property and equipment, net | 1,715 | 1,958 | ||
| Operating lease right-of-use asset | 607 | 676 | ||
| Other long-term assets | 55 | 62 | ||
| Total assets | 30,033 | 35,545 | ||
| Accounts payable | 266 | 171 | ||
| Accrued liabilities | 2,069 | 2,371 | ||
| Current operating lease liability | 452 | 439 | ||
| Total current liabilities | 2,787 | 2,981 | ||
| Operating lease liability, less current portion | 460 | 578 | ||
| Total liabilities | 3,247 | 3,559 | ||
| Common stock, 0.0001 par value 90,000,000 shares authorized at september 30, 2025 and december 31, 2024, respectively 3,943,887 and 3,904,049 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 4 | 4 | ||
| Additional paid-in capital | 455,650 | 454,240 | ||
| Accumulated other comprehensive (loss) income | -2 | -3 | ||
| Accumulated deficit | -428,866 | -422,255 | ||
| Total stockholders' equity | 26,786 | 31,986 | ||
| Total liabilities and stockholders' equity | 30,033 | 35,545 | ||
Athira Pharma, Inc. (ATHA)
Athira Pharma, Inc. (ATHA)